SCHEMBL18243684

SCHEMBL18243684

CC[CH]c1ccc(CC)cc1CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPT P10636 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ GAA P10253 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ USP2 O75604 2/20 0.37
▸ ALOX12 P18054 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ BACE1 P56817 1/20 0.36
▸ MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18242423 0.86 TRPA1 (0.36) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL5250728 0.84 TRPA1 (0.41) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL5085882 0.83 TRPA1 (0.40) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL18242160 0.83 SMN1; SMN2 (0.42) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL4905317 0.81 TRPA1 (0.43) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL29600683 0.81 TRPA1 (0.39) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL668126 0.81 TRPA1 (0.39) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL17160047 0.79 TRPA1 (0.38) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL18242339 0.78 ALDH1A1 (0.39) TRPA1CYP1A2CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL18378515 0.75 CNR1 (0.42) BACE1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1976918-A 4,5-disubstituted-2-aryl pyrimidines NEUROGEN CORP (US) 2007-06-06 — — CN claimed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 — — US disclosed
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2016-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 TRPA1 500/4885CYP1A2 360/4885CYP2A6 375/4885
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL CBR1, HAO2, CBR3 TRPA1 500/4885CYP1A2 360/4885CYP2A6 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback